Skip to main content

Advertisement

Log in

De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy

  • Liver
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83, 2002

    Article  PubMed  Google Scholar 

  2. Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S–38S, 1997

    Article  CAS  PubMed  Google Scholar 

  3. Ray RB, Meyer K, Ray R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176–182, 1996

    Article  CAS  PubMed  Google Scholar 

  4. Sherlock S: Viruses and hepatocellular carcinoma. Gut 35:828–832, 1994

    CAS  PubMed  Google Scholar 

  5. Mas VR, Maluf DG, Stravitz R, et al.: Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: Genes involved in tumor progression. Liver Transpl 10:607–620, 2004

    Article  PubMed  Google Scholar 

  6. Nishiguchi S, Kuroki T, Nakatani S, et al.: Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051–1055, 1995

    Article  CAS  PubMed  Google Scholar 

  7. Camma C, Giunta M, Andreone P, Craxi A: Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach. J Hepatol 34:593–602, 2001

    CAS  PubMed  Google Scholar 

  8. Sugiura N, Sakai Y, Ebara M, et al.: Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: Clinical study of 26 cases. J Gastroenterol Hepatol 11:535–539, 1996

    CAS  PubMed  Google Scholar 

  9. Sugo H, Kitayama N, Iwata T: Development of hepatocellular carcinoma in a patient with chronic hepatitis C after a complete response to interferon therapy. Acta Hepat Jpn 41:195–198, 2000

    Google Scholar 

  10. Yamada M, Ichikawa M, Matsubara A, Ishiguro Y, Yamada M, Yokoi S: Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C with interferon therapy. Eur J Gastroenterol Hepatol 12:1029–1032, 2000

    CAS  PubMed  Google Scholar 

  11. Makiyama A, Itoh Y, Kasahara A, et al.: Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 101:1616–1622, 2004

    Article  CAS  PubMed  Google Scholar 

  12. Yoshida H, Shiratori Y, Moriyama M, et al.: Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 131:174–181, 1999

    CAS  PubMed  Google Scholar 

  13. Kato Y, Hamasaki K, Aritomi T, Nakao K, Nakata K, Eguchi K: Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma. Oncol Rep 6:1273–1276, 1999

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin S. Sieja MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sieja, K.S., Everson, G.T. De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy. Dig Dis Sci 51, 600–602 (2006). https://doi.org/10.1007/s10620-006-3176-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3176-1

Key Words

Navigation